Arterial Hypertension and Interleukins: Potential Therapeutic Target or Future Diagnostic Marker?
International Journal of Hypertension · 2019-01 · 2019 (1)
DOI: 10.1155/2019/3159283 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Hypertension, online erschienen am 02.05.2019. Verfasst von Daniela Maria Tanase und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, "Grigore T. Popa" University of Medicine and Pharmacy, Iasi, 700111, Romania. Die Arbeit wurde bisher 117-mal zitiert (Crossref) und nennt 186 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Hypertension as a multifactorial pathology is one of the most important cardiovascular risk factors, affecting up to 30‐40% of the general population. Complex immune responses are involved in the inflammatory mechanism of hypertension, with evidence pointing to increased inflammatory mediators even in prehypertensive patients. Increased vascular permeability, thrombogenesis, and fibrosis, effects that are associated with sustained hypertension, could be attributed to chronic inflammation. Chronic inflammation triggers endothelial dysfunction via increased production of ROS through proinflammatory cytokines. Increased serum level of proinflammatory cytokines such as IL‐1 β , IL‐6, IL‐8, IL‐17, IL‐23, TGF β , and TNF α in hypertensive patients has been associated with either increased blood pressure values and/or end‐organ damage. Moreover, some cytokines (i.e., IL‐6) seem to determine a hypertensive response to angiotensin II, regardless of blood pressure values. Understanding hypertension as an inflammatory‐based pathology gives way to new therapeutic targets. As such, conventional cardiovascular drugs (statins, calcium channels blockers, and ACEIs/ARBs) have shown additional anti‐inflammatory effects that could be linked to their blood pressure lowering properties. Moreover, anti‐inflammatory drugs (mycophenolate mofetil) have been shown to decrease blood pressure in hypertensive patients or prevent its development in normotensive individuals. Further research is needed to evaluate whether drugs targeting hypertensive‐linked proinflammatory cytokines, such as monoclonal antibodies, could become a new therapeutic option in treating arterial hypertension.
Autor:innen und Institutionen
- Department of Internal Medicine, "Grigore T. Popa" University of Medicine and Pharmacy, Iasi, 700111, Romania.
- Internal Medicine Clinic, Iasi "Sf. Spiridon" County Clinical Emergency Hospital, Iasi, Romania.
- Department of Cardiology, "Prof. Dr. George I.M. Georgescu" Institute of Cardiovascular Diseases, Iasi, 700503, Romania.
- Department of Cardiology, "Grigore T. Popa" University of Medicine and Pharmacy, Iasi, 700111, Romania.
- Department of Pathophysiology, Faculty of Medicine, "Grigore T. Popa" University of Medicine and Pharmacy, Iasi, 700111, Romania.
- Department of Ophthalmology, Faculty of Medicine, "Grigore T. Popa" University of Medicine and Pharmacy, Iasi, 700111, Romania.
ORCID-Profile: Daniela Maria Tanase, Anca Ouatu, Manuela Ciocoiu, Mariana Floria
Zitieren
APA
Tanase, D. M., Gosav, E. M., Radu, S., Ouatu, A., Rezus, C., Ciocoiu, M., Costea, C. F., & Floria, M. (2019). Arterial Hypertension and Interleukins: Potential Therapeutic Target or Future Diagnostic Marker?. International Journal of Hypertension, 2019(1). https://doi.org/10.1155/2019/3159283
Vancouver
Tanase DM, Gosav EM, Radu S, Ouatu A, Rezus C, Ciocoiu M, et al. Arterial Hypertension and Interleukins: Potential Therapeutic Target or Future Diagnostic Marker?. International Journal of Hypertension. 2019;2019(1). doi:10.1155/2019/3159283
BibTeX
@article{Tanase2019,
author = {Tanase, Daniela Maria and Gosav, Evelina Maria and Radu, Smaranda and Ouatu, Anca and Rezus, Ciprian and Ciocoiu, Manuela and Costea, Claudia Florida and Floria, Mariana},
title = {Arterial Hypertension and Interleukins: Potential Therapeutic Target or Future Diagnostic Marker?},
journal = {International Journal of Hypertension},
year = {2019},
volume = {2019},
number = {1},
doi = {10.1155/2019/3159283}
}
EUVIMED